Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/14729
Title: Evaluation of clinical hypothyroidism risk due to irradiation of thyroid and pituitary glands in radiotherapy of nasopharyngeal cancer patients
Authors: Lin, Z
Wang, X
Xie, W
Yang, Z
Che, K
Wu, VW 
Keywords: Head and neck
Hypothyroidism
Nasopharyngeal carcinoma
Radiation oncology
Issue Date: 2013
Source: Journal of medical imaging and radiation oncology, 2013, v. 57, no. 6, p. 713-718 How to cite?
Journal: Journal of medical imaging and radiation oncology 
Abstract: Introduction: Radiation-induced thyroid dysfunction after radiotherapy for nasopharyngeal cancer (NPC) has been reported. This study investigated the radiation effects of the thyroid and pituitary glands on thyroid function after radiotherapy for NPC.
Methods: Sixty-five NPC patients treated with radiotherapy were recruited. Baseline thyroid hormone levels comprising free triiodothyronine (fT3), free thyroxine (fT4) and thyroid-stimulating hormone (TSH) were taken before treatment and at 3, 6, 12 and 18 months. A seven-beam intensity-modulated radiotherapy plan was generated for each patient. Thyroid and pituitary gland dose volume histograms were generated, dividing the patients into four groups: high (>50 Gy) thyroid and pituitary doses (HTHP group); high thyroid and low pituitary doses (HTLP group); low thyroid and high pituitary doses; and low thyroid and pituitary doses. Incidence of hypothyroidism was analysed.
Results: Twenty-two (34%) and 17 patients (26%) received high mean thyroid and pituitary doses, respectively. At 18 months, 23.1% of patients manifested various types of hypothyroidism. The HTHP group showed the highest incidence (83.3%) of hypothyroidism, followed by the HTLP group (50%).
Conclusions: NPC patients with high thyroid and pituitary gland doses carried the highest risk of abnormal thyroid physiology. The dose to the thyroid was more influential than the pituitary dose at 18 months after radiotherapy, and therefore more attention should be given to the thyroid gland in radiotherapy planning.
URI: http://hdl.handle.net/10397/14729
ISSN: 1754-9477(print)
1754-9485(online)
DOI: 10.1111/1754-9485.12074
Appears in Collections:Journal/Magazine Article

Access
View full-text via PolyU eLinks SFX Query
Show full item record

SCOPUSTM   
Citations

7
Citations as of Sep 18, 2017

WEB OF SCIENCETM
Citations

4
Last Week
0
Last month
0
Citations as of Sep 16, 2017

Page view(s)

46
Last Week
0
Last month
Checked on Sep 18, 2017

Google ScholarTM

Check

Altmetric



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.